Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Jane Carrie Weeks, M.D.

TitleProfessor of Medicine
InstitutionDana-Farber Cancer Institute
DepartmentMedicine
AddressDana Farber Cancer Institute
Bldg 454BRKL, Suite 21
44 Binney St
Boston MA 02115
Phone617/632-2509
Fax617/632-2270
Other Positions
TitleProfessor in the Department of Health Policy and Management
InstitutionHarvard School of Public Health
DepartmentHealth Policy and Management


 Mentoring 
 completed student projects
Assessing Women's Preferences for Breast Cancer Risk Reduction
Part Time/Continuation, 09/01/99 - 01/31/00
Assessing Women's Preferences for Breast Cancer Risk Reduction
Summer, 06/28/99 - 08/30/99

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Catalano PJ, Ayanian JZ, Weeks JC, Kahn KL, Landrum MB, Zaslavsky AM, Lee J, Pendergast J, Harrington DP. Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care. 2013 Feb; 51(2):e9-15.
    View in: PubMed
  2. Weeks JC, Mack JW, Schrag D. Talking with patients about dying. N Engl J Med. 2013 Jan 31; 368(5):480-1.
    View in: PubMed
  3. Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D. Palliative Radiation Therapy Practice in Patients With Metastatic Non-Small-Cell Lung Cancer: A Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol. 2013 Feb 10; 31(5):558-64.
    View in: PubMed
  4. Malin JL, Weeks JC, Potosky AL, Hornbrook MC, Keating NL. Medical oncologists' perceptions of financial incentives in cancer care. J Clin Oncol. 2013 Feb 10; 31(5):530-5.
    View in: PubMed
  5. Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, Breslin TM, Hudis CA, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC. Time to adjuvant chemotherapy for breast cancer in national comprehensive cancer network institutions. J Natl Cancer Inst. 2013 Jan 16; 105(2):104-12.
    View in: PubMed
  6. Mack JW, Cronin A, Keating NL, Taback N, Huskamp HA, Malin JL, Earle CC, Weeks JC. Associations Between End-of-Life Discussion Characteristics and Care Received Near Death: A Prospective Cohort Study. J Clin Oncol. 2012 Dec 10; 30(35):4387-95.
    View in: PubMed
  7. Abel GA, Chen K, Taback N, Hassett MJ, Schrag D, Weeks JC. Impact of oncology-related direct-to-consumer advertising: Association with appropriate and inappropriate prescriptions. Cancer. 2013 Mar 1; 119(5):1065-72.
    View in: PubMed
  8. Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH. Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat. 2012 Dec; 136(3):813-21.
    View in: PubMed
  9. Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D. Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012 Oct 25; 367(17):1616-25.
    View in: PubMed
  10. Halasz LM, Weeks JC, Neville BA, Taback N, Punglia RS. Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys. 2013 Feb 1; 85(2):e109-16.
    View in: PubMed
  11. Freedman RA, Hughes ME, Ottesen RA, Weeks JC, He Y, Wong YN, Theriault R, Keating NL. Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network. Cancer. 2013 Feb 15; 119(4):839-46.
    View in: PubMed
  12. Zafar SY, Malin JL, Grambow SC, Abbott DH, Kolimaga JT, Zullig LL, Weeks JC, Ayanian JZ, Kahn KL, Ganz PA, Catalano PJ, West DW, Provenzale D. Chemotherapy use and patient treatment preferences in advanced colorectal cancer: A prospective cohort study. Cancer. 2013 Feb 15; 119(4):854-62.
    View in: PubMed
  13. Isaac T, Stuver SO, Davis RB, Block S, Weeks JC, Berry DL, Weingart SN. Incidence of severe pain in newly diagnosed ambulatory patients with stage IV cancer. Pain Res Manag. 2012 Sep-Oct; 17(5):347-52.
    View in: PubMed
  14. Hu YY, Kwok AC, Jiang W, Taback N, Loggers ET, Ting GV, Lipsitz SR, Weeks JC, Greenberg CC. High-cost imaging in elderly patients with stage IV cancer. J Natl Cancer Inst. 2012 Aug 8; 104(15):1164-72.
    View in: PubMed
  15. McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS. Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal. 2012 Jul; 32 Suppl 1:S117-24.
    View in: PubMed
  16. Zhu J, Davis RB, Stuver SO, Berry DL, Block S, Weeks JC, Weingart SN. A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer. Cancer. 2012 Dec 15; 118(24):6278-86.
    View in: PubMed
  17. Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ. Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. Cancer. 2012 Dec 15; 118(24):6022-30.
    View in: PubMed
  18. Weingart SN, Cleary A, Stuver SO, Lynch M, Brandoff D, Schaefer KG, Zhu J, Berry DL, Block S, Weeks JC. Assessing the quality of pain care in ambulatory patients with advanced stage cancer. J Pain Symptom Manage. 2012 Jun; 43(6):1072-81.
    View in: PubMed
  19. Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC. Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol. 2012 Jun 20; 30(18):2218-26.
    View in: PubMed
  20. Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012; 17(6):775-82.
    View in: PubMed
  21. In H, Neville BA, Lipsitz SR, Corso KA, Weeks JC, Greenberg CC. The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence. Ann Surg. 2012 May; 255(5):890-5.
    View in: PubMed
  22. Lin NU, Vanderplas A, Hughes ME, Theriault RL, Edge SB, Wong YN, Blayney DW, Niland JC, Winer EP, Weeks JC. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer. 2012 Nov 15; 118(22):5463-72.
    View in: PubMed
  23. Zhu J, Sharma DB, Gray SW, Chen AB, Weeks JC, Schrag D. Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA. 2012 Apr 18; 307(15):1593-601.
    View in: PubMed
  24. Burdette AM, Weeks J, Hill TD, Eberstein IW. Maternal religious attendance and low birth weight. Soc Sci Med. 2012 Jun; 74(12):1961-7.
    View in: PubMed
  25. Stuver SO, Isaac T, Weeks JC, Block S, Berry DL, Davis RB, Weingart SN. Factors associated with pain among ambulatory patients with cancer with advanced disease at a comprehensive cancer center. J Oncol Pract. 2012 Jul; 8(4):e17-23.
    View in: PubMed
  26. Delate T, Witt DM, Ritzwoller D, Weeks JC, Kushi L, Hornbrook MC, Aiello Bowles EJ, Schrag D. Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27.
    View in: PubMed
  27. Mack JW, Cronin A, Taback N, Huskamp HA, Keating NL, Malin JL, Earle CC, Weeks JC. End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med. 2012 Feb 7; 156(3):204-10.
    View in: PubMed
  28. Sanoff HK, Carpenter WR, Martin CF, Sargent DJ, Meyerhardt JA, Stürmer T, Fine JP, Weeks J, Niland J, Kahn KL, Schymura MJ, Schrag D. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst. 2012 Feb 8; 104(3):211-27.
    View in: PubMed
  29. Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. Fertil Steril. 2012 Jan; 97(1):154-9.
    View in: PubMed
  30. Romanus D, Kindler HL, Archer L, Basch E, Niedzwiecki D, Weeks J, Schrag D. Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). J Pain Symptom Manage. 2012 Feb; 43(2):205-17.
    View in: PubMed
  31. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, Johnson BE, Weeks JC, Gazelle GS. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011 Nov; 6(11):1841-8.
    View in: PubMed
  32. Potosky AL, Malin JL, Kim B, Chrischilles EA, Weeks JC. Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy. J Natl Cancer Inst. 2011 Dec 21; 103(24):1899-901; author reply 1901-3.
    View in: PubMed
  33. Zafar SY, Malin JL, Grambow SC, Abbott DH, Schrag D, Kolimaga JT, Zullig LL, Weeks JC, Fouad MN, Ayanian JZ, Wallace R, Kahn KL, Ganz PA, Catalano P, West DW, Provenzale D. Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer. 2011; 11:354.
    View in: PubMed
  34. Truong TH, Weeks JC, Cook EF, Joffe S. Altruism among participants in cancer clinical trials. Clin Trials. 2011 Oct; 8(5):616-23.
    View in: PubMed
  35. Brewster AM, Etzel C, Zhou R, Wong Y, Edge S, Blayney DW, Wilson J, Hudis C, Ottesen R, Hughes ME, Weeks JC, Theriault RL. The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers. Breast Cancer Res Treat. 2011 Dec; 130(3):897-904.
    View in: PubMed
  36. Greenberg CC, Lipsitz SR, Hughes ME, Edge SB, Theriault R, Wilson JL, Carter WB, Blayney DW, Niland J, Weeks JC. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Ann Surg. 2011 Aug; 254(2):339-45.
    View in: PubMed
  37. Saito AM, Landrum MB, Neville BA, Ayanian JZ, Weeks JC, Earle CC. Hospice care and survival among elderly patients with lung cancer. J Palliat Med. 2011 Aug; 14(8):929-39.
    View in: PubMed
  38. Punglia RS, Burstein HJ, Weeks JC. Radiation therapy for ductal carcinoma in situ: a decision analysis. Cancer. 2012 Feb 1; 118(3):603-11.
    View in: PubMed
  39. Greenberg CC, Lipsitz SR, Neville B, In H, Hevelone N, Porter SA, Weeks C, Jha AK, Gawande AA, Schrag D, Weeks JC. Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg. 2011 Oct; 146(10):1128-34.
    View in: PubMed
  40. Potosky AL, Malin JL, Kim B, Chrischilles EA, Makgoeng SB, Howlader N, Weeks JC. Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst. 2011 Jun 22; 103(12):979-82.
    View in: PubMed
  41. Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC. Parents' roles in decision making for children with cancer in the first year of cancer treatment. J Clin Oncol. 2011 May 20; 29(15):2085-90.
    View in: PubMed
  42. Stucky CC, Pockaj BA, Novotny PJ, Sloan JA, Sargent DJ, O'Connell MJ, Beart RW, Skibber JM, Nelson H, Weeks JC. Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Ann Surg Oncol. 2011 Sep; 18(9):2422-31.
    View in: PubMed
  43. Wong YN, Ottesen RA, Hughes ME, Niland JC, Theriault R, Edge SB, Blayney D, Weeks JC. Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence? Oncologist. 2011; 16(5):559-65.
    View in: PubMed
  44. Galarce EM, Ramanadhan S, Weeks J, Schneider EC, Gray SW, Viswanath K. Class, race, ethnicity and information needs in post-treatment cancer patients. Patient Educ Couns. 2011 Dec; 85(3):432-9.
    View in: PubMed
  45. Truong TH, Weeks JC, Cook EF, Joffe S. Outcomes of informed consent among parents of children in cancer clinical trials. Pediatr Blood Cancer. 2011 Dec 1; 57(6):998-1004.
    View in: PubMed
  46. Dussel V, Bona K, Heath JA, Hilden JM, Weeks JC, Wolfe J. Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer. J Clin Oncol. 2011 Mar 10; 29(8):1007-13.
    View in: PubMed
  47. Keating NL, Beth Landrum M, Arora NK, Malin JL, Ganz PA, van Ryn M, Weeks JC. Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol. 2010 Oct 1; 28(28):4364-70.
    View in: PubMed
  48. Ayanian JZ, Zaslavsky AM, Arora NK, Kahn KL, Malin JL, Ganz PA, van Ryn M, Hornbrook MC, Kiefe CI, He Y, Urmie JM, Weeks JC, Harrington DP. Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. 2010 Sep 20; 28(27):4154-61.
    View in: PubMed
  49. Alderman AK, Collins ED, Schott A, Hughes ME, Ottesen RA, Theriault RL, Wong YN, Weeks JC, Niland JC, Edge SB. The impact of breast reconstruction on the delivery of chemotherapy. Cancer. 2010 Apr 1; 116(7):1791-800.
    View in: PubMed
  50. Kahn KL, Adams JL, Weeks JC, Chrischilles EA, Schrag D, Ayanian JZ, Kiefe CI, Ganz PA, Bhoopalam N, Potosky AL, Harrington DP, Fletcher RH. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA. 2010 Mar 17; 303(11):1037-45.
    View in: PubMed
  51. Punglia RS, Saito AM, Neville BA, Earle CC, Weeks JC. Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis. BMJ. 2010; 340:c845.
    View in: PubMed
  52. Earle CC, Chretien Y, Morris C, Ayanian JZ, Keating NL, Polgreen LA, Wallace R, Ganz PA, Weeks JC. Employment among survivors of lung cancer and colorectal cancer. J Clin Oncol. 2010 Apr 1; 28(10):1700-5.
    View in: PubMed
  53. Dussel V, Joffe S, Hilden JM, Watterson-Schaeffer J, Weeks JC, Wolfe J. Considerations about hastening death among parents of children who die of cancer. Arch Pediatr Adolesc Med. 2010 Mar; 164(3):231-7.
    View in: PubMed
  54. Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer. 2010 Feb 15; 116(4):791-8.
    View in: PubMed
  55. Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG. End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol. 2010 Mar 1; 28(7):1203-8.
    View in: PubMed
  56. Chrischilles EA, Pendergast JF, Kahn KL, Wallace RB, Moga DC, Harrington DP, Kiefe CI, Weeks JC, West DW, Zafar SY, Fletcher RH. Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol. 2010 Feb 1; 28(4):620-7.
    View in: PubMed
  57. Ozanne EM, Wittenberg E, Garber JE, Weeks JC. Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J. 2010 Jan-Feb; 16(1):38-47.
    View in: PubMed
  58. Sever A, Jones S, Cox K, Weeks J, Mills P, Jones P. Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasonography in patients with breast cancer. Br J Surg. 2009 Nov; 96(11):1295-9.
    View in: PubMed
  59. Abel GA, Burstein HJ, Hevelone ND, Weeks JC. Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment. J Clin Oncol. 2009 Sep 1; 27(25):4182-7.
    View in: PubMed
  60. Keating NL, Kouri E, He Y, Weeks JC, Winer EP. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care. 2009 Jul; 47(7):765-73.
    View in: PubMed
  61. Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC. Peace of mind and sense of purpose as core existential issues among parents of children with cancer. Arch Pediatr Adolesc Med. 2009 Jun; 163(6):519-24.
    View in: PubMed
  62. Huskamp HA, Keating NL, Malin JL, Zaslavsky AM, Weeks JC, Earle CC, Teno JM, Virnig BA, Kahn KL, He Y, Ayanian JZ. Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med. 2009 May 25; 169(10):954-62.
    View in: PubMed
  63. Svahn TH, Niland JC, Carlson RW, Hughes ME, Ottesen RA, Theriault RL, Edge SB, Schott AF, Bookman MA, Weeks JC. Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer. J Natl Compr Canc Netw. 2009 Feb; 7(2):115-21.
    View in: PubMed
  64. Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg. 2009 Feb; 208(2):202-9.
    View in: PubMed
  65. McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS. Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer. 2008 Dec 15; 113(12):3440-9.
    View in: PubMed
  66. Kho ME, Lepisto EM, Niland JC, Friedberg JW, Lacasce AS, Weeks JC. Reliability of staging, prognosis, and comorbidity data collection in the National Comprehensive Cancer Network (NCCN) non-Hodgkin lymphoma (NHL) multicenter outcomes database. Cancer. 2008 Dec 1; 113(11):3209-12.
    View in: PubMed
  67. Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC. Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer. J Clin Oncol. 2008 Dec 1; 26(34):5553-60.
    View in: PubMed
  68. Hannemann M, Weeks J, Evans A, Pring A, Hirschowitz L. Incidence, pathology and outcome of gynaecological cancer in patients under the age of 21 years in South-west England 1995-2004: comparison of data from regional, national and international registries. J Obstet Gynaecol. 2008 Oct; 28(7):722-7.
    View in: PubMed
  69. Mack JW, Joffe S, Hilden JM, Watterson J, Moore C, Weeks JC, Wolfe J. Parents' views of cancer-directed therapy for children with no realistic chance for cure. J Clin Oncol. 2008 Oct 10; 26(29):4759-64.
    View in: PubMed
  70. LaCasce AS, Kho ME, Friedberg JW, Niland JC, Abel GA, Rodriguez MA, Czuczman MS, Millenson MM, Zelenetz AD, Weeks JC. Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol. 2008 Nov 1; 26(31):5107-12.
    View in: PubMed
  71. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008 Aug 10; 26(23):3860-6.
    View in: PubMed
  72. Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. Selecting high priority quality measures for breast cancer quality improvement. Med Care. 2008 Aug; 46(8):762-70.
    View in: PubMed
  73. Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, Donaldson MS, Kahn KL, Weeks JC, Ko CY, Stewart AK, Edge SB. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol. 2008 Jul 20; 26(21):3631-7.
    View in: PubMed
  74. Abel GA, Neufeld EJ, Sorel M, Weeks JC. Direct-to-consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims. J Thromb Haemost. 2008 Oct; 6(10):1680-4.
    View in: PubMed
  75. Jackson VA, Mack J, Matsuyama R, Lakoma MD, Sullivan AM, Arnold RM, Weeks JC, Block SD. A qualitative study of oncologists' approaches to end-of-life care. J Palliat Med. 2008 Jul; 11(6):893-906.
    View in: PubMed
  76. Dussel V, Kreicbergs U, Hilden JM, Watterson J, Moore C, Turner BG, Weeks JC, Wolfe J. Looking beyond where children die: determinants and effects of planning a child's location of death. J Pain Symptom Manage. 2009 Jan; 37(1):33-43.
    View in: PubMed
  77. Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC. Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network. Int J Radiat Oncol Biol Phys. 2008 Dec 1; 72(5):1434-40.
    View in: PubMed
  78. McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology. 2008 Jul; 248(1):278-87.
    View in: PubMed
  79. Punglia RS, Burstein HJ, Winer EP, Weeks JC. Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. J Natl Cancer Inst. 2008 May 7; 100(9):642-8.
    View in: PubMed
  80. Greenberg CC, Weeks JC, Stain SC. Disparities in oncologic surgery. World J Surg. 2008 Apr; 32(4):522-8.
    View in: PubMed
  81. Wolfe J, Hammel JF, Edwards KE, Duncan J, Comeau M, Breyer J, Aldridge SA, Grier HE, Berde C, Dussel V, Weeks JC. Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol. 2008 Apr 1; 26(10):1717-23.
    View in: PubMed
  82. Lamont EB, Herndon JE, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, Christakis NA. Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants. Med Care. 2008 Mar; 46(3):303-8.
    View in: PubMed
  83. Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008 Feb 20; 100(4):243-51.
    View in: PubMed
  84. Greenberg CC, Schneider EC, Lipsitz SR, Ko CY, Malin JL, Epstein AM, Weeks JC, Kahn KL. Do variations in provider discussions explain socioeconomic disparities in postmastectomy breast reconstruction? J Am Coll Surg. 2008 Apr; 206(4):605-15.
    View in: PubMed
  85. Mack JW, Wolfe J, Cook EF, Grier HE, Cleary PD, Weeks JC. Hope and prognostic disclosure. J Clin Oncol. 2007 Dec 10; 25(35):5636-42.
    View in: PubMed
  86. Albritton KH, Wiggins CH, Nelson HE, Weeks JC. Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol. 2007 Oct 10; 25(29):4616-21.
    View in: PubMed
  87. DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007 Oct; 30(5):697-705.
    View in: PubMed
  88. O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007 Oct; 30(5):687-96.
    View in: PubMed
  89. Mack JW, Co JP, Goldmann DA, Weeks JC, Cleary PD. Quality of health care for children: role of health and chronic illness in inpatient care experiences. Arch Pediatr Adolesc Med. 2007 Sep; 161(9):828-34.
    View in: PubMed
  90. Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. J Clin Oncol. 2007 Aug 1; 25(22):3251-8.
    View in: PubMed
  91. Steyerberg EW, Neville B, Weeks JC, Earle CC. Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2007 Jun 10; 25(17):2389-96.
    View in: PubMed
  92. Mack JW, Cook EF, Wolfe J, Grier HE, Cleary PD, Weeks JC. Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction. J Clin Oncol. 2007 Apr 10; 25(11):1357-62.
    View in: PubMed
  93. Falconer AD, Hirschowitz L, Weeks J, Murdoch J. The impact of improving outcomes guidance on surgical management of vulval squamous cell cancer in southwest England (1997-2002). BJOG. 2007 Apr; 114(4):391-7.
    View in: PubMed
  94. Abel GA, Lee SJ, Weeks JC. Direct-to-consumer advertising in oncology: a content analysis of print media. J Clin Oncol. 2007 Apr 1; 25(10):1267-71.
    View in: PubMed
  95. Krzyzanowska MK, Earle CC, Kuntz KM, Weeks JC. Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2007 Jan 1; 67(1):211-8.
    View in: PubMed
  96. Mack JW, Wolfe J, Grier HE, Cleary PD, Weeks JC. Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol. 2006 Nov 20; 24(33):5265-70.
    View in: PubMed
  97. Lamont EB, Herndon JE, Weeks JC, Henderson IC, Earle CC, Schilsky RL, Christakis NA. Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst. 2006 Sep 20; 98(18):1335-8.
    View in: PubMed
  98. Steyerberg EW, Neville BA, Koppert LB, Lemmens VE, Tilanus HW, Coebergh JW, Weeks JC, Earle CC. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol. 2006 Sep 10; 24(26):4277-84.
    View in: PubMed
  99. McMahon PM, Zaslavsky AM, Weinstein MC, Kuntz KM, Weeks JC, Gazelle GS. Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Med Decis Making. 2006 Sep-Oct; 26(5):497-511.
    View in: PubMed
  100. Punglia RS, Weeks JC, Neville BA, Earle CC. Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information. J Clin Oncol. 2006 Jul 20; 24(21):3474-82.
    View in: PubMed
  101. Punglia RS, Weeks JC, Neville BA, Earle CC. Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys. 2006 Sep 1; 66(1):56-63.
    View in: PubMed
  102. Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis. Cancer. 2006 Jun 15; 106(12):2576-82.
    View in: PubMed
  103. Oh WK, Hayes J, Evan C, Manola J, George DJ, Waldron H, Donovan M, Varner J, Orechia J, Katcher B, Lu D, Nevins A, Wright RL, Tormey L, Talcott J, Rubin MA, Loda M, Sellers WR, Richie JP, Kantoff PW, Weeks J. Development of an integrated prostate cancer research information system. Clin Genitourin Cancer. 2006 Jun; 5(1):61-6.
    View in: PubMed
  104. Paskett ED, Schrag D, Kornblith A, Lamont EB, Weeks JC, Marshall JR, Shapiro C, Holland J. Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments. Clin Cancer Res. 2006 Jun 1; 12(11 Pt 2):3601s-5s.
    View in: PubMed
  105. Wittenberg E, Halpern E, Divi N, Prosser LA, Araki SS, Weeks JC. The effect of age, race and gender on preference scores for hypothetical health states. Qual Life Res. 2006 May; 15(4):645-53.
    View in: PubMed
  106. Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE, Zhang C, Mayer RJ. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol. 2006 Mar 20; 24(9):1395-403.
    View in: PubMed
  107. Christian CK, Niland J, Edge SB, Ottesen RA, Hughes ME, Theriault R, Wilson J, Hergrueter CA, Weeks JC. A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg. 2006 Feb; 243(2):241-9.
    View in: PubMed
  108. Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, Bookman MA, Weeks JC. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. 2006 Jan 20; 24(3):361-9.
    View in: PubMed
  109. Bailey J, Murdoch J, Anderson R, Weeks J, Foy C. Stage III and IV ovarian cancer in the South West of England: five-year outcome analysis for cases treated in 1998. Int J Gynecol Cancer. 2006 Jan-Feb; 16 Suppl 1:25-9.
    View in: PubMed
  110. Mack JW, Hilden JM, Watterson J, Moore C, Turner B, Grier HE, Weeks JC, Wolfe J. Parent and physician perspectives on quality of care at the end of life in children with cancer. J Clin Oncol. 2005 Dec 20; 23(36):9155-61.
    View in: PubMed
  111. Elkin EB, Weinstein MC, Kuntz KM, Bunnell CA, Weeks JC. Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs. Breast Cancer Res Treat. 2005 Sep; 93(1):25-34.
    View in: PubMed
  112. Emmons KM, Puleo E, Park E, Gritz ER, Butterfield RM, Weeks JC, Mertens A, Li FP. Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. J Clin Oncol. 2005 Sep 20; 23(27):6516-23.
    View in: PubMed
  113. Lamont EB, Herndon JE, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, Christakis NA. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants. J Natl Cancer Inst. 2005 Jul 20; 97(14):1080-3.
    View in: PubMed
  114. Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis. J Clin Oncol. 2005 Aug 1; 23(22):5178-87.
    View in: PubMed
  115. Earle CC, Neville BA, Landrum MB, Souza JM, Weeks JC, Block SD, Grunfeld E, Ayanian JZ. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care. 2005 Dec; 17(6):505-9.
    View in: PubMed
  116. Emmons KM, Stoddard AM, Fletcher R, Gutheil C, Suarez EG, Lobb R, Weeks J, Bigby JA. Cancer prevention among working class, multiethnic adults: results of the healthy directions-health centers study. Am J Public Health. 2005 Jul; 95(7):1200-5.
    View in: PubMed
  117. Hensley ML, Dowell J, Herndon JE, Winer E, Stark N, Weeks JC, Paskett E. Economic outcomes of breast cancer survivorship: CALGB study 79804. Breast Cancer Res Treat. 2005 May; 91(2):153-61.
    View in: PubMed
  118. Wittenberg E, Winer EP, Weeks JC. Patient utilities for advanced cancer: effect of current health on values. Med Care. 2005 Feb; 43(2):173-81.
    View in: PubMed
  119. Steyerberg EW, Earle CC, Neville BA, Weeks JC. Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol. 2005 Jan 20; 23(3):510-7.
    View in: PubMed
  120. Lilenbaum RC, Herndon JE, List MA, Desch C, Watson DM, Miller AA, Graziano SL, Perry MC, Saville W, Chahinian P, Weeks JC, Holland JC, Green MR. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol. 2005 Jan 1; 23(1):190-6.
    View in: PubMed
  121. Danilowicz C, Kafri Y, Conroy RS, Coljee VW, Weeks J, Prentiss M. Measurement of the phase diagram of DNA unzipping in the temperature-force plane. Phys Rev Lett. 2004 Aug 13; 93(7):078101.
    View in: PubMed
  122. Ayanian JZ, Chrischilles EA, Fletcher RH, Fouad MN, Harrington DP, Kahn KL, Kiefe CI, Lipscomb J, Malin JL, Potosky AL, Provenzale DT, Sandler RS, van Ryn M, Wallace RB, Weeks JC, West DW. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol. 2004 Aug 1; 22(15):2992-6.
    View in: PubMed
  123. Joffe S, Harrington DP, George SL, Emanuel EJ, Budzinski LA, Weeks JC. Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis. BMJ. 2004 Jun 19; 328(7454):1463.
    View in: PubMed
  124. Chapman RH, Berger M, Weinstein MC, Weeks JC, Goldie S, Neumann PJ. When does quality-adjusting life-years matter in cost-effectiveness analysis? Health Econ. 2004 May; 13(5):429-36.
    View in: PubMed
  125. Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC. HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol. 2004 Mar 1; 22(5):854-63.
    View in: PubMed
  126. Ng AK, Li S, Neuberg D, Silver B, Weeks J, Mauch P. Factors influencing treatment recommendations in early-stage Hodgkin's disease: a survey of physicians. Ann Oncol. 2004 Feb; 15(2):261-9.
    View in: PubMed
  127. Peppercorn JM, Weeks JC, Cook EF, Joffe S. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet. 2004 Jan 24; 363(9405):263-70.
    View in: PubMed
  128. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004 Jan 15; 22(2):315-21.
    View in: PubMed
  129. Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, Schrag D, Ayanian JZ, O'Connell MJ, Weeks JC, Mayer RJ, Willett CG, MacDonald JS, Benson AB, Fuchs CS. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. J Clin Oncol. 2004 Jan 1; 22(1):166-74.
    View in: PubMed
  130. Edge SB, Niland JC, Bookman MA, Theriault RL, Ottesen R, Lepisto E, Weeks JC. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst. 2003 Oct 15; 95(20):1514-21.
    View in: PubMed
  131. Krzyzanowska MK, Weeks JC, Earle CC. Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol. 2003 Sep 15; 21(18):3409-14.
    View in: PubMed
  132. Goldman DP, Berry SH, McCabe MS, Kilgore ML, Potosky AL, Schoenbaum ML, Schonlau M, Weeks JC, Kaplan R, Escarce JJ. Incremental treatment costs in national cancer institute-sponsored clinical trials. JAMA. 2003 Jun 11; 289(22):2970-7.
    View in: PubMed
  133. Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC. Optimistic expectations and survival after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2003 Jun; 9(6):389-96.
    View in: PubMed
  134. Keating NL, Weeks JC, Borbas C, Guadagnoli E. Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed? Breast Cancer Res Treat. 2003 May; 79(2):225-31.
    View in: PubMed
  135. Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003 Apr 15; 21(8):1447-51.
    View in: PubMed
  136. Hadley J, Mandelblatt JS, Mitchell JM, Weeks JC, Guadagnoli E, Hwang YT. Medicare breast surgery fees and treatment received by older women with localized breast cancer. Health Serv Res. 2003 Apr; 38(2):553-73.
    View in: PubMed
  137. Joffe S, Manocchia M, Weeks JC, Cleary PD. What do patients value in their hospital care? An empirical perspective on autonomy centred bioethics. J Med Ethics. 2003 Apr; 29(2):103-8.
    View in: PubMed
  138. Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003 Mar 15; 21(6):1133-8.
    View in: PubMed
  139. Polsky D, Mandelblatt JS, Weeks JC, Venditti L, Hwang YT, Glick HA, Hadley J, Schulman KA. Economic evaluation of breast cancer treatment: considering the value of patient choice. J Clin Oncol. 2003 Mar 15; 21(6):1139-46.
    View in: PubMed
  140. Hadley J, Polsky D, Mandelblatt JS, Mitchell JM, Weeks JC, Wang Q, Hwang YT. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population. Health Econ. 2003 Mar; 12(3):171-86.
    View in: PubMed
  141. Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson BM, Hwang YT, Kerner J, Weeks J. Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. J Clin Oncol. 2003 Mar 1; 21(5):855-63.
    View in: PubMed
  142. Cella D, Paul D, Yount S, Winn R, Chang CH, Banik D, Weeks J. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Invest. 2003; 21(4):526-35.
    View in: PubMed
  143. Joffe S, Weeks JC. Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst. 2002 Dec 18; 94(24):1847-53.
    View in: PubMed
  144. Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson B, Hwang YT, Weeks JC. Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma. Cancer. 2002 Dec 15; 95(12):2445-54.
    View in: PubMed
  145. Polsky D, Keating NL, Weeks JC, Schulman KA. Patient choice of breast cancer treatment: impact on health state preferences. Med Care. 2002 Nov; 40(11):1068-79.
    View in: PubMed
  146. Lehmann LS, Weeks JC, Klar N, Garber JE. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing. Genet Med. 2002 Sep-Oct; 4(5):346-52.
    View in: PubMed
  147. Grunberg SM, Srivastava A, Grunberg KJ, Weeks J. Intensity of chemotherapy-induced emesis and overall survival as determinants of a global utility score. Support Care Cancer. 2002 Nov; 10(8):624-9.
    View in: PubMed
  148. Loberiza FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002 Apr 15; 20(8):2118-26.
    View in: PubMed
  149. Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol. 2002 Apr 1; 20(7):1786-92.
    View in: PubMed
  150. Keating NL, Guadagnoli E, Landrum MB, Borbas C, Weeks JC. Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement? J Clin Oncol. 2002 Mar 15; 20(6):1473-9.
    View in: PubMed
  151. Kilbridge KL, Cole BF, Kirkwood JM, Haluska FG, Atkins MA, Ruckdeschel JC, Sock DE, Nease RF, Weeks JC. Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data. J Clin Oncol. 2002 Mar 1; 20(5):1311-8.
    View in: PubMed
  152. Liang W, Burnett CB, Rowland JH, Meropol NJ, Eggert L, Hwang YT, Silliman RA, Weeks JC, Mandelblatt JS. Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol. 2002 Feb 15; 20(4):1008-16.
    View in: PubMed
  153. Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G. Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA. 2002 Jan 16; 287(3):321-8.
    View in: PubMed
  154. Olaitan A, Weeks J, Mocroft A, Smith J, Howe K, Murdoch J. The surgical management of women with ovarian cancer in the south west of England. Br J Cancer. 2001 Dec 14; 85(12):1824-30.
    View in: PubMed
  155. Gurwitz JH, Guadagnoli E, Landrum MB, Silliman RA, Wolf R, Weeks JC. The treating physician as active gatekeeper in the recruitment of research subjects. Med Care. 2001 Dec; 39(12):1339-44.
    View in: PubMed
  156. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001 Nov 24; 358(9295):1772-7.
    View in: PubMed
  157. Ng AK, Kuntz KM, Mauch PM, Weeks JC. Costs and effectiveness of staging and treatment options in early-stage Hodgkin's disease. Int J Radiat Oncol Biol Phys. 2001 Jul 15; 50(4):979-89.
    View in: PubMed
  158. Stewart D, Weeks J, Bent S. Utilization, patient satisfaction, and cost implications of acupuncture, massage, and naturopathic medicine offered as covered health benefits: a comparison of two delivery models. Altern Ther Health Med. 2001 Jul-Aug; 7(4):66-70.
    View in: PubMed
  159. Keating NL, Weeks JC, Landrum MB, Borbas C, Guadagnoli E. Discussion of treatment options for early-stage breast cancer: effect of provider specialty on type of surgery and satisfaction. Med Care. 2001 Jul; 39(7):681-91.
    View in: PubMed
  160. Lee SJ, Fairclough D, Antin JH, Weeks JC. Discrepancies between patient and physician estimates for the success of stem cell transplantation. JAMA. 2001 Feb 28; 285(8):1034-8.
    View in: PubMed
  161. Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol. 2001 Feb 15; 19(4):1064-70.
    View in: PubMed
  162. Kilbridge KL, Weeks JC, Sober AJ, Haluska FG, Slingluff CL, Atkins MB, Sock DE, Kirkwood JM, Nease RF. Patient preferences for adjuvant interferon alfa-2b treatment. J Clin Oncol. 2001 Feb 1; 19(3):812-23.
    View in: PubMed
  163. Walters ET, Illich PA, Weeks JC, Lewin MR. Defensive responses of larval Manduca sexta and their sensitization by noxious stimuli in the laboratory and field. J Exp Biol. 2001 Feb; 204(Pt 3):457-69.
    View in: PubMed
  164. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst. 2001 Jan 17; 93(2):139-47.
    View in: PubMed
  165. Lee SJ, Fairclough D, Parsons SK, Soiffer RJ, Fisher DC, Schlossman RL, Antin JH, Weeks JC. Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol. 2001 Jan 1; 19(1):242-52.
    View in: PubMed
  166. Goldman DP, Schoenbaum ML, Potosky AL, Weeks JC, Berry SH, Escarce JJ, Weidmer BA, Kilgore ML, Wagle N, Adams JL, Figlin RA, Lewis JH, Cohen J, Kaplan R, McCabe M. Measuring the incremental cost of clinical cancer research. J Clin Oncol. 2001 Jan 1; 19(1):105-10.
    View in: PubMed
  167. Lehmann LS, Weeks JC, Klar N, Biener L, Garber JE. Disclosure of familial genetic information: perceptions of the duty to inform. Am J Med. 2000 Dec 15; 109(9):705-11.
    View in: PubMed
  168. Wolfe J, Klar N, Grier HE, Duncan J, Salem-Schatz S, Emanuel EJ, Weeks JC. Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care. JAMA. 2000 Nov 15; 284(19):2469-75.
    View in: PubMed
  169. Galper SR, Lee SJ, Tao ML, Troyan S, Kaelin CM, Harris JR, Weeks JC. Patient preferences for axillary dissection in the management of early-stage breast cancer. J Natl Cancer Inst. 2000 Oct 18; 92(20):1681-7.
    View in: PubMed
  170. Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffith J, Edge S, Guadagnoli E, Lynch JJ, Meropol NJ, Weeks JC, Winn R. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer. 2000 Aug 1; 89(3):561-73.
    View in: PubMed
  171. Earle CC, Venditti LN, Neumann PJ, Gelber RD, Weinstein MC, Potosky AL, Weeks JC. Who gets chemotherapy for metastatic lung cancer? Chest. 2000 May; 117(5):1239-46.
    View in: PubMed
  172. Guadagnoli E, Soumerai SB, Gurwitz JH, Borbas C, Shapiro CL, Weeks JC, Morris N. Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback. Breast Cancer Res Treat. 2000 May; 61(2):171-5.
    View in: PubMed
  173. Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, Emanuel EJ, Weeks JC. Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000 Feb 3; 342(5):326-33.
    View in: PubMed
  174. Lee SJ, Earle CC, Weeks JC. Outcomes research in oncology: history, conceptual framework, and trends in the literature. J Natl Cancer Inst. 2000 Feb 2; 92(3):195-204.
    View in: PubMed
  175. Schrag D, Kuntz KM, Garber JE, Weeks JC. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA. 2000 Feb 2; 283(5):617-24.
    View in: PubMed
  176. Hillner BE, Weeks JC, Desch CE, Smith TJ. Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol. 2000 Jan; 18(1):72-9.
    View in: PubMed
  177. Hayman JA, Hillner BE, Harris JR, Pierce LJ, Weeks JC. Cost-effectiveness of adding an electron-beam boost to tangential radiation therapy in patients with negative margins after conservative surgery for early-stage breast cancer. J Clin Oncol. 2000 Jan; 18(2):287-95.
    View in: PubMed
  178. Lee SJ, Klar N, Weeks JC, Antin JH. Predicting costs of stem-cell transplantation. J Clin Oncol. 2000 Jan; 18(1):64-71.
    View in: PubMed
  179. Ng AK, Weeks JC, Mauch PM, Kuntz KM. Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease. J Clin Oncol. 1999 Nov; 17(11):3577-85.
    View in: PubMed
  180. Schrag D, Weeks J. Costs and cost-effectiveness of colorectal cancer prevention and therapy. Semin Oncol. 1999 Oct; 26(5):561-8.
    View in: PubMed
  181. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999 Jun 3; 340(22):1733-9.
    View in: PubMed
  182. Weeks J. Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network. Oncology (Williston Park). 1999 May; 13(5A):69-71.
    View in: PubMed
  183. Rosendahl I, Kiebert GM, Curran D, Cole BF, Weeks JC, Denis LJ, Hall RR. Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer. Prostate. 1999 Feb 1; 38(2):100-9.
    View in: PubMed
  184. Earle CC, Weeks JC. Evidence-based medicine: a cup half full or half empty? Am J Med. 1999 Feb; 106(2):263-4.
    View in: PubMed
  185. Ng AK, Weeks JC, Mauch PM, Kuntz KM. Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: a decision analysis. J Clin Oncol. 1999 Jan; 17(1):241-52.
    View in: PubMed
  186. Lee SJ, Anasetti C, Kuntz KM, Patten J, Antin JH, Weeks JC. The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia. Blood. 1998 Dec 1; 92(11):4047-52.
    View in: PubMed
  187. Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998 Nov 15; 129(10):787-96.
    View in: PubMed
  188. Haidet P, Hamel MB, Davis RB, Wenger N, Reding D, Kussin PS, Connors AF, Lynn J, Weeks JC, Phillips RS. Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Med. 1998 Sep; 105(3):222-9.
    View in: PubMed
  189. Guadagnoli E, Shapiro CL, Weeks JC, Gurwitz JH, Borbas C, Soumerai SB. The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines? Cancer. 1998 Jul 15; 83(2):302-9.
    View in: PubMed
  190. Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors AF, Lynn J, Phillips RS. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA. 1998 Jun 3; 279(21):1709-14.
    View in: PubMed
  191. Weeks J. Overview of outcomes research and management and its role in oncology practice. Oncology (Williston Park). 1998 Mar; 12(3 Suppl 4):11-3.
    View in: PubMed
  192. Hayman JA, Hillner BE, Harris JR, Weeks JC. Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. J Clin Oncol. 1998 Mar; 16(3):1022-9.
    View in: PubMed
  193. O'Brien BJ, Goeree R, Gafni A, Torrance GW, Pauly MV, Erder H, Rusthoven J, Weeks J, Cahill M, LaMont B. Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care. Med Care. 1998 Mar; 36(3):370-84.
    View in: PubMed
  194. Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol. 1998 Jan; 16(1):275-83.
    View in: PubMed
  195. Guadagnoli E, Weeks JC, Shapiro CL, Gurwitz JH, Borbas C, Soumerai SB. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol. 1998 Jan; 16(1):101-6.
    View in: PubMed
  196. Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH. Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis. Ann Intern Med. 1997 Dec 15; 127(12):1080-8.
    View in: PubMed
  197. Weeks JC. Outcomes assessment in the NCCN. Oncology (Williston Park). 1997 Nov; 11(11A):137-40.
    View in: PubMed
  198. Guadagnoli E, Shapiro C, Gurwitz JH, Silliman RA, Weeks JC, Borbas C, Soumerai SB. Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer. J Clin Oncol. 1997 Jun; 15(6):2338-44.
    View in: PubMed
  199. Schrag D, Kuntz KM, Garber JE, Weeks JC. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997 May 15; 336(20):1465-71.
    View in: PubMed
  200. Weeks JC. A guide for the guideline reader. Breast Cancer Res Treat. 1997 May; 43(3):277-8.
    View in: PubMed
  201. Hayman JA, Fairclough DL, Harris JR, Weeks JC. Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol. 1997 Mar; 15(3):1252-60.
    View in: PubMed
  202. Weeks J, Pfister DG. Outcomes research studies. Oncology (Williston Park). 1996 Nov; 10(11 Suppl):29-34.
    View in: PubMed
  203. Todd MM, Weeks J. Comparative effects of propofol, pentobarbital, and isoflurane on cerebral blood flow and blood volume. J Neurosurg Anesthesiol. 1996 Oct; 8(4):296-303.
    View in: PubMed
  204. Bennett CL, Smith TJ, Weeks JC, Bredt AB, Feinglass J, Fetting JH, Hillner BE, Somerfield MR, Winn RJ. Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology. J Clin Oncol. 1996 Sep; 14(9):2511-20.
    View in: PubMed
  205. Hayman J, Weeks J, Mauch P. Economic analyses in health care: an introduction to the methodology with an emphasis on radiation therapy. Int J Radiat Oncol Biol Phys. 1996 Jul 1; 35(4):827-41.
    View in: PubMed
  206. Travis LB, Weeks J, Curtis RE, Chaffey JT, Stovall M, Banks PM, Boice JD. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma. J Clin Oncol. 1996 Feb; 14(2):565-71.
    View in: PubMed
  207. Weeks J. Taking quality of life into account in health economic analyses. J Natl Cancer Inst Monogr. 1996; (20):23-7.
    View in: PubMed
  208. Weeks J. Measurement of utilities and quality-adjusted survival. Oncology (Williston Park). 1995 Nov; 9(11 Suppl):67-70.
    View in: PubMed
  209. O'Leary JF, Fairclough DL, Jankowski MK, Weeks JC. Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship. Med Decis Making. 1995 Apr-Jun; 15(2):132-7.
    View in: PubMed
  210. Weeks JC. Special issues that arise in applying techniques of economic analysis to evaluation of cancer therapies. J Natl Cancer Inst Monogr. 1995; (19):11-2.
    View in: PubMed
  211. Weeks JC. Economic considerations in comparing whole abdominal radiotherapy with combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: how much economic data should be collected? J Natl Cancer Inst Monogr. 1995; (19):17-9.
    View in: PubMed
  212. Le PP, Kohane IS, Weeks JC. Using a pen-based computer to collect health-related quality of life and utilities information. Proc Annu Symp Comput Appl Med Care. 1995; 839-43.
    View in: PubMed
  213. Nelson H, Weeks JC, Wieand HS. Proposed phase III trial comparing laparoscopic-assisted colectomy versus open colectomy for colon cancer. J Natl Cancer Inst Monogr. 1995; (19):51-6.
    View in: PubMed
  214. Weeks JC. Preferences of older cancer patients: can you judge a book by its cover? J Natl Cancer Inst. 1994 Dec 7; 86(23):1743-4.
    View in: PubMed
  215. Tsevat J, Weeks JC, Guadagnoli E, Tosteson AN, Mangione CM, Pliskin JS, Weinstein MC, Cleary PD. Using health-related quality-of-life information: clinical encounters, clinical trials, and health policy. J Gen Intern Med. 1994 Oct; 9(10):576-82.
    View in: PubMed
  216. Hall JC, Harris J, Weeks J. Educational interventions and the use of parenteral nutrition. J Qual Clin Pract. 1994 Sep; 14(3):131-6.
    View in: PubMed
  217. Ota DM, Nelson H, Weeks JC. Controversies regarding laparoscopic colectomy for malignant diseases. Curr Opin Gen Surg. 1994; 208-13.
    View in: PubMed
  218. Weeks J. Quality-of-life assessment: performance status upstaged? J Clin Oncol. 1992 Dec; 10(12):1827-9.
    View in: PubMed
  219. Weeks JC, Tierney MR, Weinstein MC. Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med. 1991 Jul 11; 325(2):81-6.
    View in: PubMed
  220. Weeks JC, Yeap BY, Canellos GP, Shipp MA. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol. 1991 Jul; 9(7):1196-203.
    View in: PubMed
  221. Frei E, Kass F, Weeks J. Quality of life in cancer patients: clinical considerations and perspectives. Oncology (Williston Park). 1990 May; 4(5):204-7; discussion 208.
    View in: PubMed
  222. Breatnach E, Weeks J. Unusual intrapulmonary tumor. A rare cause of bronchiectasis. Chest. 1990 Jan; 97(1):197-8.
    View in: PubMed
  223. Peterson BA, Weeks JC. Somatotopic mapping of sensory neurons innervating mechanosensory hairs on the larval prolegs of Manduca sexta. J Comp Neurol. 1988 Sep 1; 275(1):128-44.
    View in: PubMed
  224. Wallace HM, Weeks J, Medina A. Services for pregnant teenagers in the large cities of the United States, 1970-1980. JAMA. 1982 Nov 12; 248(18):2270-3.
    View in: PubMed
  225. Weeks J, Best G, Cheyne J, Leopold E. Distribution of room size in hospitals. Health Serv Res. 1976; 11(3):227-40.
    View in: PubMed
  226. Weeks J, Best G. Design strategy for flexible health sciences facilities. Health Serv Res. 1970; 5(3):263-84.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu. SPH faculty should contact Maria Maxell (mmaxellhsph.harvard.edu).
Weeks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (634) concept(s)
_
Co-Authors
See all (107) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_